Tempus Introduces 'Preview': Bridging the Critical Time Gap Between Diagnostic Order and Definitive Results

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the introduction of Tempus Previe